QUÉBEC CITY, Aug. 3
/PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX:
AEZ), ("the Company") a late-stage drug development company
specialized in oncology and endocrinology, today announced that its
Senior Vice President and Chief Medical Officer, Paul Blake, MD, will present a corporate
overview at the upcoming Canaccord Genuity 30th Annual Growth
Conference on Thursday, August 12,
2010, at 3:00 p.m. ET, in the
Montreal Room of the InterContinental Boston, in Boston.
A live webcast of the presentation will be available on Aeterna
Zentaris' website at www.aezsinc.com in the Investors section. A
replay will also be available for a period of 30 days on the
Company's website.
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a late-stage drug development company
specialized in oncology and endocrinology. News releases and
additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Copyright g. 3 PR Newswire